lkpl biotech (LPBI) subsidiary formed-
here's a copy of email i got from bob jones yesterday:
Recently, Link Plus Corporation (LKPL) signed an exclusive worldwide agreement with the University of Maryland for their Molecularly Imprinted Polymers (MIPs) for the binding and separation of viruses and, eventually, bacteria.
To successfully address the commercial potential of this new MIPs technology, a subsidiary company of LKPL has been established with the sole purpose of developing commercial products based on this technology. This subsidiary is Link Plus BioTech, Inc. (LPBI). The parent company, Link Plus Corporation, will continue to focus on Homeland Security applications.
I (bob jones) have been appointed Chairman and CEO of LPBI, and Dr. Peter Kofinas, Professor, Associate Chair and Director of Graduate Studies in University of Maryland's Fischell Department of Bioengineering, has accepted the position of Chief Technical Officer of LPBI and Daniel Janiak, a doctoral candidate at Maryland, has agreed to be Principal Scientist. Dr. Kofinas and Mr. Janiak are the co-inventors of the technology.
